Guizhou Yibai Pharmaceutical Co Ltd (600594) — Free Cash Flow Generation Index
Guizhou Yibai Pharmaceutical Co Ltd (600594) has a Free Cash Flow Generation Index of 0.79x as of September 2025. Free cash flow of CN¥26.20 Million represents 1% of operating cash flow (CN¥33.28 Million). See Guizhou Yibai Pharmaceutical Co Ltd (600594) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Guizhou Yibai Pharmaceutical Co Ltd Free Cash Flow Generation Index (2002–2025)
Historical FCF Generation Index trend for Guizhou Yibai Pharmaceutical Co Ltd across 23 annual periods. Explore Guizhou Yibai Pharmaceutical Co Ltd (600594) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)
Year-by-year Free Cash Flow Generation Index for Guizhou Yibai Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 600594 market cap overview.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.86x | CN¥221.71 Million | CN¥256.71 Million | CN¥34.99 Million | ▲ +894.1% |
| 2024 | -0.11x | CN¥-9.45 Million | CN¥86.87 Million | CN¥96.32 Million | ▼ -116.6% |
| 2023 | 0.65x | CN¥247.23 Million | CN¥377.61 Million | CN¥130.38 Million | ▲ +910.4% |
| 2022 | 0.06x | CN¥22.38 Million | CN¥345.30 Million | CN¥322.92 Million | ▼ -87.6% |
| 2021 | 0.52x | CN¥486.43 Million | CN¥934.21 Million | CN¥447.78 Million | ▲ +756.5% |
| 2020 | -0.08x | CN¥-29.08 Million | CN¥366.66 Million | CN¥395.74 Million | ▼ -117.8% |
| 2019 | 0.45x | CN¥161.44 Million | CN¥362.71 Million | CN¥201.28 Million | ▲ +189.1% |
| 2018 | -0.50x | CN¥-107.03 Million | CN¥214.30 Million | CN¥321.33 Million | ▼ -222.1% |
| 2017 | 0.41x | CN¥278.98 Million | CN¥681.78 Million | CN¥402.80 Million | ▲ +223.9% |
| 2016 | 0.13x | CN¥48.08 Million | CN¥380.62 Million | CN¥332.53 Million | ▼ -74.6% |
| 2015 | 0.50x | CN¥285.66 Million | CN¥573.68 Million | CN¥288.02 Million | ▼ -20.1% |
| 2014 | 0.62x | CN¥337.65 Million | CN¥541.58 Million | CN¥203.94 Million | ▲ +18.5% |
| 2013 | 0.53x | CN¥303.76 Million | CN¥577.24 Million | CN¥273.48 Million | ▲ +93.4% |
| 2012 | 0.27x | CN¥78.37 Million | CN¥288.01 Million | CN¥209.64 Million | ▼ -44.2% |
| 2011 | 0.49x | CN¥135.49 Million | CN¥277.83 Million | CN¥142.34 Million | ▼ -14.5% |
| 2010 | 0.57x | CN¥66.01 Million | CN¥115.66 Million | CN¥49.66 Million | ▲ +0.0% |
| 2009 | 0.57x | CN¥59.26 Million | CN¥103.88 Million | CN¥44.62 Million | ▼ -14.6% |
| 2008 | 0.67x | CN¥126.40 Million | CN¥189.26 Million | CN¥62.86 Million | ▲ +129.5% |
| 2007 | -2.26x | CN¥-27.03 Million | CN¥11.94 Million | CN¥38.97 Million | ▼ -375.1% |
| 2006 | 0.82x | CN¥78.77 Million | CN¥95.77 Million | CN¥17.00 Million | ▲ +122.5% |
| 2005 | -3.66x | CN¥-63.60 Million | CN¥17.38 Million | CN¥80.99 Million | ▼ -335.6% |
| 2003 | -0.84x | CN¥-77.37 Million | CN¥92.10 Million | CN¥169.47 Million | ▼ -221.1% |
| 2002 | 0.69x | CN¥50.97 Million | CN¥73.46 Million | CN¥22.49 Million | — |